These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 14617582

  • 1. Edrophonium effectively antagonizes neuromuscular block at the laryngeal adductors induced by rapacuronium, rocuronium and cisatracurium, but not mivacurium.
    Suzuki T, Lien CA, Belmont MR, Tjan J, Savarese JJ.
    Can J Anaesth; 2003 Nov; 50(9):879-85. PubMed ID: 14617582
    [Abstract] [Full Text] [Related]

  • 2. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block.
    Naguib M, Riad W.
    Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536
    [Abstract] [Full Text] [Related]

  • 3. Atracurium, cisatracurium, vecuronium and rocuronium in patients with renal failure.
    Della Rocca G, Pompei L, Coccia C, Costa MG, Cecchini V, Vilardi V, Pietropaoli P.
    Minerva Anestesiol; 2003 Nov; 69(7-8):605-11, 612, 5. PubMed ID: 14564242
    [Abstract] [Full Text] [Related]

  • 4. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ, Beaufort TM, Fuchs-Buder T.
    Drugs; 2001 Nov; 61(7):919-42. PubMed ID: 11434449
    [Abstract] [Full Text] [Related]

  • 5. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O, White PF, Tufanogullari B, Klein K.
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [Abstract] [Full Text] [Related]

  • 6. Edrophonium antagonism of cisatracurium-induced neuromuscular block: dose requirements in children and adults.
    Abdulatif M, El-Sanabary M.
    Anaesth Intensive Care; 2001 Aug; 29(4):364-70. PubMed ID: 11512646
    [Abstract] [Full Text] [Related]

  • 7. Edrophonium antagonism of intense mivacurium-induced neuromuscular block in children.
    Abdulatif M, Al-Ghamdi A, Al-Sanabary M, Abdel-Gaffar ME.
    Br J Anaesth; 1996 Feb; 76(2):239-44. PubMed ID: 8777104
    [Abstract] [Full Text] [Related]

  • 8. Optimum dose of neostigmine to reverse shallow neuromuscular blockade with rocuronium and cisatracurium.
    Choi ES, Oh AY, Seo KS, Hwang JW, Ryu JH, Koo BW, Kim BG.
    Anaesthesia; 2016 Apr; 71(4):443-9. PubMed ID: 26874258
    [Abstract] [Full Text] [Related]

  • 9. [Influence of neostigmine on the course of neuromuscular blockade with rocuronium or cisatracurium: a randomized, double-blind trial].
    Barrio J, San Miguel G, García V, Pelegrín F.
    Rev Esp Anestesiol Reanim; 2007 Apr; 54(7):399-404. PubMed ID: 17953333
    [Abstract] [Full Text] [Related]

  • 10. Neuromuscular blocking effects and train-of-four fade with cisatracurium: comparison with other nondepolarising relaxants.
    Carroll MT, Mirakhur RK, Lowry DW, McCourt KC, Kerr C.
    Anaesthesia; 1998 Dec; 53(12):1169-73. PubMed ID: 10193219
    [Abstract] [Full Text] [Related]

  • 11. Priming rapacuronium: a comparison with rocuronium and mivacurium.
    Steinberg D.
    Acta Cient Venez; 2003 Dec; 54(2):115-20. PubMed ID: 14976782
    [Abstract] [Full Text] [Related]

  • 12. Antagonism of rapacuronium using edrophonium or neostigmine: pharmacodynamics and pharmacokinetics.
    Mills KG, Wright PM, Pollard BJ, Scott JM, Hing JP, Danjoux G, Hunter JM.
    Br J Anaesth; 1999 Nov; 83(5):727-33. PubMed ID: 10690134
    [Abstract] [Full Text] [Related]

  • 13. Antagonism of profound cisatracurium and rocuronium block: the role of objective assessment of neuromuscular function.
    Kopman AF, Kopman DJ, Ng J, Zank LM.
    J Clin Anesth; 2005 Feb; 17(1):30-5. PubMed ID: 15721727
    [Abstract] [Full Text] [Related]

  • 14. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination.
    Kim KS, Chun YS, Chon SU, Suh JK.
    Anaesthesia; 1998 Sep; 53(9):872-8. PubMed ID: 9849281
    [Abstract] [Full Text] [Related]

  • 15. [Neostigmine and edrophonium. Antagonism of profound and shallow mivacurium blockade].
    Bartunek A, Gilly H, Huemer G, Yildiz S, Schramm W, Lackner FX, Foldes FF.
    Anaesthesist; 1997 Feb; 46(2):96-100. PubMed ID: 9133184
    [Abstract] [Full Text] [Related]

  • 16. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex.
    White PF, Tufanogullari B, Sacan O, Pavlin EG, Viegas OJ, Minkowitz HS, Hudson ME.
    Anesth Analg; 2009 Mar; 108(3):846-51. PubMed ID: 19224792
    [Abstract] [Full Text] [Related]

  • 17. Reversal of mivacurium chloride: edrophonium of spontaneous recovery in microscopic laryngeal surgery.
    Ting CK, Lin SM, Yang YW, Tsai HJ, Lao HC, Chu YC, Tsai SK.
    Acta Anaesthesiol Sin; 2001 Dec; 39(4):157-62. PubMed ID: 11840581
    [Abstract] [Full Text] [Related]

  • 18. A comparison of edrophonium and neostigmine for the antagonism of atracurium-induced neuromuscular block.
    Lavery GG, Mirakhur RK, Gibson FM.
    Anesth Analg; 1985 Sep; 64(9):867-70. PubMed ID: 3161421
    [Abstract] [Full Text] [Related]

  • 19. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
    Arain SR, Kern S, Ficke DJ, Ebert TJ.
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of neuromuscular effects and antagonism of rocuronium bromide: a preliminary report.
    Davis L, Jayarajah MJ, Toner CC, Flynn PJ.
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():65-8. PubMed ID: 8557009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.